BOSTON SCIENTIFIC CORP (BSX) Stock Fundamental Analysis
USA - NYSE:BSX - US1011371077 - Common Stock
97.65 USD
-0.58 (-0.59%)
Overall BSX gets a fundamental rating of 6 out of 10. We evaluated BSX against 191 industry peers in the Health Care Equipment & Supplies industry. BSX scores excellent on profitability, but there are some minor concerns on its financial health. BSX is growing strongly while it is still valued neutral. This is a good combination! These ratings could make BSX a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
In the past year BSX was profitable.
BSX had a positive operating cash flow in the past year.
BSX had positive earnings in 4 of the past 5 years.
BSX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.03%, BSX belongs to the top of the industry, outperforming 83.77% of the companies in the same industry.
Looking at the Return On Equity, with a value of 11.17%, BSX belongs to the top of the industry, outperforming 86.91% of the companies in the same industry.
BSX has a better Return On Invested Capital (7.66%) than 84.29% of its industry peers.
BSX had an Average Return On Invested Capital over the past 3 years of 6.54%. This is in line with the industry average of 8.46%.
The last Return On Invested Capital (7.66%) for BSX is above the 3 year average (6.54%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.03% | ||
| ROE | 11.17% | ||
| ROIC | 7.66% |
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.54%
ROIC(5y)5.68%
1.3 Margins
BSX's Profit Margin of 13.54% is amongst the best of the industry. BSX outperforms 90.05% of its industry peers.
In the last couple of years the Profit Margin of BSX has declined.
BSX's Operating Margin of 18.69% is amongst the best of the industry. BSX outperforms 90.58% of its industry peers.
BSX's Operating Margin has been stable in the last couple of years.
BSX's Gross Margin of 68.30% is fine compared to the rest of the industry. BSX outperforms 75.39% of its industry peers.
In the last couple of years the Gross Margin of BSX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.69% | ||
| PM (TTM) | 13.54% | ||
| GM | 68.3% |
OM growth 3Y0.33%
OM growth 5Y1.13%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.3%
GM growth 5Y-0.65%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BSX is destroying value.
The number of shares outstanding for BSX has been increased compared to 1 year ago.
Compared to 5 years ago, BSX has more shares outstanding
Compared to 1 year ago, BSX has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.48 indicates that BSX is not in any danger for bankruptcy at the moment.
BSX has a better Altman-Z score (5.48) than 81.68% of its industry peers.
BSX has a debt to FCF ratio of 3.33. This is a good value and a sign of high solvency as BSX would need 3.33 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.33, BSX belongs to the top of the industry, outperforming 86.39% of the companies in the same industry.
BSX has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.50, BSX is in line with its industry, outperforming 40.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 3.33 | ||
| Altman-Z | 5.48 |
ROIC/WACC0.93
WACC8.27%
2.3 Liquidity
BSX has a Current Ratio of 1.37. This is a normal value and indicates that BSX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BSX (1.37) is worse than 77.49% of its industry peers.
A Quick Ratio of 0.82 indicates that BSX may have some problems paying its short term obligations.
With a Quick ratio value of 0.82, BSX is not doing good in the industry: 84.82% of the companies in the same industry are doing better.
The current and quick ratio evaluation for BSX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.91% over the past year.
BSX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.56% yearly.
The Revenue has grown by 21.45% in the past year. This is a very strong growth!
The Revenue has been growing by 9.30% on average over the past years. This is quite good.
EPS 1Y (TTM)26.91%
EPS 3Y15.48%
EPS 5Y9.56%
EPS Q2Q%20.97%
Revenue 1Y (TTM)21.45%
Revenue growth 3Y12.1%
Revenue growth 5Y9.3%
Sales Q2Q%22.84%
3.2 Future
Based on estimates for the next years, BSX will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.08% on average per year.
Based on estimates for the next years, BSX will show a quite strong growth in Revenue. The Revenue will grow by 11.70% on average per year.
EPS Next Y20.01%
EPS Next 2Y16.91%
EPS Next 3Y15.57%
EPS Next 5Y14.08%
Revenue Next Year19.6%
Revenue Next 2Y15.24%
Revenue Next 3Y13.53%
Revenue Next 5Y11.7%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 34.51 indicates a quite expensive valuation of BSX.
72.25% of the companies in the same industry are more expensive than BSX, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.41. BSX is valued slightly more expensive when compared to this.
A Price/Forward Earnings ratio of 28.46 indicates a quite expensive valuation of BSX.
72.77% of the companies in the same industry are more expensive than BSX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.88. BSX is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.51 | ||
| Fwd PE | 28.46 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BSX is valued a bit cheaper than the industry average as 71.20% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BSX indicates a somewhat cheap valuation: BSX is cheaper than 76.96% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.53 | ||
| EV/EBITDA | 32.82 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of BSX may justify a higher PE ratio.
A more expensive valuation may be justified as BSX's earnings are expected to grow with 15.57% in the coming years.
PEG (NY)1.72
PEG (5Y)3.61
EPS Next 2Y16.91%
EPS Next 3Y15.57%
5. Dividend
5.1 Amount
BSX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:BSX (9/19/2025, 11:23:10 AM)
97.65
-0.58 (-0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners93.45%
Inst Owner Change0.03%
Ins Owners0.15%
Ins Owner Change-2.45%
Market Cap144.69B
Analysts85
Price Target126.25 (29.29%)
Short Float %1.29%
Short Ratio2.69
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.53%
Min EPS beat(2)2.49%
Max EPS beat(2)10.56%
EPS beat(4)4
Avg EPS beat(4)6.23%
Min EPS beat(4)2.49%
Max EPS beat(4)10.56%
EPS beat(8)8
Avg EPS beat(8)6.12%
EPS beat(12)11
Avg EPS beat(12)5.14%
EPS beat(16)15
Avg EPS beat(16)4.28%
Revenue beat(2)2
Avg Revenue beat(2)1.7%
Min Revenue beat(2)0.97%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)2.15%
Min Revenue beat(4)0.97%
Max Revenue beat(4)3.16%
Revenue beat(8)8
Avg Revenue beat(8)2.1%
Revenue beat(12)11
Avg Revenue beat(12)2.01%
Revenue beat(16)12
Avg Revenue beat(16)1.41%
PT rev (1m)0.38%
PT rev (3m)5.49%
EPS NQ rev (1m)-0.09%
EPS NQ rev (3m)2.36%
EPS NY rev (1m)2.19%
EPS NY rev (3m)2.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)1.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.51 | ||
| Fwd PE | 28.46 | ||
| P/S | 7.82 | ||
| P/FCF | 41.53 | ||
| P/OCF | 33.78 | ||
| P/B | 6.45 | ||
| P/tB | N/A | ||
| EV/EBITDA | 32.82 |
EPS(TTM)2.83
EY2.9%
EPS(NY)3.43
Fwd EY3.51%
FCF(TTM)2.35
FCFY2.41%
OCF(TTM)2.89
OCFY2.96%
SpS12.48
BVpS15.13
TBVpS-1.97
PEG (NY)1.72
PEG (5Y)3.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.03% | ||
| ROE | 11.17% | ||
| ROCE | 9.51% | ||
| ROIC | 7.66% | ||
| ROICexc | 7.77% | ||
| ROICexgc | 26.52% | ||
| OM | 18.69% | ||
| PM (TTM) | 13.54% | ||
| GM | 68.3% | ||
| FCFM | 18.84% |
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.54%
ROIC(5y)5.68%
ROICexc(3y)6.7%
ROICexc(5y)5.9%
ROICexgc(3y)22.68%
ROICexgc(5y)19.43%
ROCE(3y)8.12%
ROCE(5y)7.05%
ROICexcg growth 3Y8.56%
ROICexcg growth 5Y6.81%
ROICexc growth 3Y4.36%
ROICexc growth 5Y5.23%
OM growth 3Y0.33%
OM growth 5Y1.13%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.3%
GM growth 5Y-0.65%
F-Score5
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 3.33 | ||
| Debt/EBITDA | 2.33 | ||
| Cap/Depr | 60.84% | ||
| Cap/Sales | 4.33% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 89.77% | ||
| Profit Quality | 139.08% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 5.48 |
F-Score5
WACC8.27%
ROIC/WACC0.93
Cap/Depr(3y)57.82%
Cap/Depr(5y)54.13%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.85%
Profit Quality(3y)134.31%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.91%
EPS 3Y15.48%
EPS 5Y9.56%
EPS Q2Q%20.97%
EPS Next Y20.01%
EPS Next 2Y16.91%
EPS Next 3Y15.57%
EPS Next 5Y14.08%
Revenue 1Y (TTM)21.45%
Revenue growth 3Y12.1%
Revenue growth 5Y9.3%
Sales Q2Q%22.84%
Revenue Next Year19.6%
Revenue Next 2Y15.24%
Revenue Next 3Y13.53%
Revenue Next 5Y11.7%
EBIT growth 1Y26.44%
EBIT growth 3Y12.47%
EBIT growth 5Y10.54%
EBIT Next Year35.67%
EBIT Next 3Y20.23%
EBIT Next 5Y14.94%
FCF growth 1Y131.03%
FCF growth 3Y26.15%
FCF growth 5Y16.61%
OCF growth 1Y101.7%
OCF growth 3Y22.44%
OCF growth 5Y13.34%